Key result
Serum visfatin levels were significantly higher in patients with coronary heart disease and positively correlated with coronary artery stenosis severity (Gensini score r=0.669, P<0.01).
Why the study?
Is serum visfatin level associated with the severity of coronary artery stenosis in patients with different glucose tolerance statuses?
Cross-Sectional (n=115)
Is serum visfatin level associated with the severity of coronary artery stenosis in patients with different glucose tolerance statuses?
Effect estimate: r=0.669
p-value: p=<0.01
Serum visfatin levels correlate with the severity of coronary artery stenosis and metabolic risk factors, suggesting its potential as a biomarker for assessing coronary heart disease severity.
Visfatin was associated with stenosis severity; hypothesis-generating for biomarker utility across glucose tolerance statuses, pending prospective studies.
Objective To investigate the relationship between serum visfatin level and coronary artery stenosis.Methods Based on coronary angiography,85 patients were diagnosed as coronary heart disease.According to oral glucose tolerance test,these patients were divided into 3 groups,34 patients with normal glucose tolerance(CHD group),25 with impaired glucose regulation(CIG group),and 26 with type 2 diabetes mellitus(CDM group).30 non-comary heart disease subjects with normal glucose tolerance were selected as the control group(CON group),and they underwent coronary CT angiography scan and were confirmed coronary disease-free.Blood pressure,body mass index(BMI),waist circumference(WC),waist hip ratio(WHR),fasting plasma glucose(FPG),blood lipid analysis,fasting insulin,and HbA1C were determined.Serum visfatin concentration was assayed and the status of coronary artery was assessed.Coronary artery stenosis was screened by coronary interventional angiography and assessed by Gemini scoring system in CHD,CIG,and CDM groups.Results Compared with control group,serum visfatin in CHD,CIG,and CDM groups were significantly higher(all P<0.05).Compared with CHD group,serum visfatin in CIG and CDM groups were significantly higher(all P<0.05).The correlation analysis showed that serum visfatin level was positively correlated with the involved branches of coronary arteries(r=0.807,P<0.01),serum visfatin level was positively related with Gensini coronary artery score(r=0.669,P<0.01).Visfatin was also positively correlated with WC,WHR,triglyceride(TG,r=0.200,P=0.032,r=0.185,P=0.047,r=0.321,P<0.01),while high density lipoprotein cholesterol(HDL-C)was negatively correlated with visfatin(r=-0.354,P<0.01).Multiple regression analysis showed that senlm hvel of TG and WC were the main influencing factors of visfatin.Conclusion (1)The level of serum visfatin may reflect the severity of coronary artery stenosis,detection of visfatin helps to make early diagnosis of CHD.(2)The raised serum level of visfatin in comary heart disease patients with imparied glucose tolerance is consistent with clinical evidence that diabetic patients have more severe coronary diseases.(3)WC and serum TG are main inilucencing factors,suggesting that visfatin is correlated with abdominal obesity.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2011) conducted a cross-sectional in Coronary heart disease and glucose tolerance (n=115). Serum visfatin level vs. Control group (non-coronary heart disease with normal glucose tolerance) was evaluated on Coronary artery stenosis severity (Gensini score) (r=0.669, p=<0.01). Serum visfatin levels were significantly higher in patients with coronary heart disease and positively correlated with coronary artery stenosis severity (Gensini score r=0.669, P<0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: